WHO ICTRP trial
Lactate infusion in GLUT1DS
EUCTR2019-003676-39-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-003676-39-NL |
|---|---|
| Public title | Lactate infusion in GLUT1DS |
| Scientific title | Effects of sodium lactate infusion in patients with glucose transporter 1 deficiency syndrome (GLUT1DS) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Netherlands |
| Conditions | In glucose transporter 1 deficiency syndrome (GLUT1DS) cerebral glucose uptake from the systemic blood circulation is limited, because of deficient transport of glucose across the blood-brain barrier by the transporter protein (GLUT1)… |
| Interventions | Trade Name: sodiumlactate Pharmaceutical Form: Powder for solution for infusion |
| Registration date | Sep 6, 2020 |
| Target size | 4 |
| Secondary IDs | 109147 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: